Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (p...
Q1 2026
May 13, 2026
FY 2025
Mar 12, 2026
Q4 2025
Q3 2025
Nov 5, 2025
Q2 2025
Aug 7, 2025